Document Type : Original Article
Authors
- . Omran Davarinejad 1
- . Fatemeh RostamiParsa 1
- . Farnaz Radmehr 1
- . Vahid Farnia 2
- . Mostafa Alikhani 2
1 Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract
BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diseases,
and obsessive–compulsive disorder (OCD) is one of the main causes of this disease. The present
study was aimed to investigate the prevalence of OCD in patients with IBS.
MATERIALS AND METHODS: The present research is a cross‑sectional survey study. The research
sample included 120 patients with IBS who referred to Imam Reza Hospital and gastrointestinal
clinics in Kermanshah (Iran) in the 3 months of April, May, July in 2019 that were selected using the
census sampling method, and demographic information, clinical and medical records were collected.
Data analysis was performed using frequency, percentage, and Chi‑square.
RESULTS: Among the patients who were studied, 58 of them (48.3%) were women and 62 (51.7%)
were men, the results showed that the prevalence of OCD in patients with IBS was 14.96 and the
symptoms of washing, checking, skepticism and slowness‑repetition had the highest prevalence,
respectively. These symptoms were more common in women than in men. There was also a significant
relation between OCD prevalence in patients with IBS and with female gender, age‑range 30–21 years,
single, and history of OCD in the patient’s immediate family and close relatives (P < 0.05), but there
was no significant relationship between OCD prevalence in patients with IBS and level of education,
occupation, income status, and place of residence
CONCLUSION: Due to the high prevalence of OCD in patients with IBS, the interaction of
gastroenterologists and psychiatrists to treat irritable bowel syndrome is very important.
Keywords
low‑FODMAP sourdoughs for patients with coeliac disease
and irritable bowel syndrome: A clinical perspective. Int J Food
Microbiol 2019;290:237‑46.
2. Cifre S, Gozalbo M, Ortiz V, Soriano JM, Merino JF, Trelis M.
Blastocystis subtypes and their association with irritable bowel
syndrome. J Medi Hypotheses 2018;116:4‑9.
3. Afshar H, BagherianSararoodi R, Foroozandeh N, Khorramian N,
Daghaghzadeh H, Merati MR, Adibi P. The relationship between
Illness perception and symptom severity in patients with Irritable
bowel syndrome. J Isfahan Med Sch 2011;29:526‑36.
4. Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M,
Spiller R. Bowel disorders. Gastroenterology 2016;150:1393‑407.
5. Quigley EM, Fried M, Gwee KA, KhalifI, Hungin AP, Lindberg G,
et al. World gastroenterology organisation global guidelines
irritable bowel syndrome: A global perspective update September
2015. J Clin Gastroenterol 2016;50:704‑13.
6. Faeli A, Mohammadifar MA, Azizpour M, Dabiri R. Comparison
of personality traits and quality of life between patients with
irritable bowel syndrome and normal indiv iduals. J Clini Psycho
2017;9:1‑10.
7. Singh R, Salem A, Nanavati J, Mullin GE. The role of diet in the
treatment of irritable bowel syndrome: A systematic review.
Gastroenterol Clin North Am 2018;47:107‑37.
8. Dibajnia P, Moghadasin M, KeykhayeFarzaneh MM. The Study
of the relationship between psychological disorders with Irritable
bowel syndrome. Pajouhandeh J 2012;18:30‑3.
9. GrundmannO, Yoon SL. Irritable bowel syndrome: Epidemiology,
diagnosis and treatment: An update for health‑care practitioners. Gastroenterol Hepatol 2010;25:691‑9.
10. Posserud I, Svedlund J, Wallin J, Simrén M. Hypervigilance in
irritable bowel syndrome compared with organic gastrointestinal
disease. J Psychosom Res 2009;66:399‑405.
11. Gros DF, Antony MM, McCabe RE, Swinson RP. Frequency and
severity of the symptoms of irritable bowel syndrome across the
anxiety disorders and depression. J Anxiety Disord 2009;23:290‑6.
12. Masand PS, Keuthen NJ, Gupta S, Virk S, Yu‑Siao B, Kaplan D.
Prevalence of irritable bowel syndrome in obsessive‑compulsive
disorder. CNS Spectr 2006;11:21‑5.
13. Mahvi‑Shirazi M, Fathi‑Ashtiani A, Rasoolzadeh‑Tabatabaei SK,
Amini M. Comparison of mental health the mental health
levels of patients suffering from irritable bowel synsrome, and
inflammatory bowel disease, and healthy people. J of Resea in
Psychologl Healt 2008;2:75‑83.
14. Safaralizadeh F, Hashemloo L, Bagheriyeh F, Motearefi H. The
prevalence obsessive‑compulsive disorder in students in Khoy
University in 2013. Iran J Psychi Nurs 2014;2:13‑21.
15. American Psychiatric Association. Diagnoostic and Statistical
Manual of Mental Disorder. In: Rezaee F, et al. (5th Ed‑DSM‑5)
American Psychiatric Publishing; 2013. Tehran: Arjmand
Publication; 2015.
16. Sadock BJ, Sadock VA, Ruiz P. Kaplan HI, Sadock BJ. Synopsis
of psychiatry. In: Rezaee F, editor. Behavioral Sciences/Clinical
Psychiatry. Tehran: Arjmand Publication; 2015.
17. Brown LA, Wakschal E, Russman‑Block S, Boisseau CL,
Mancebo MC, Eisen JL, et al. Directionality of change in obsessive
compulsive disorder (OCD) and suicidal ideation over six years
in a naturalistic clinical sample. J Affect Disord 2019;245:841‑7.
18. Rachid F. Transcranial direct current stimulation for the treatment
of obsessive‑compulsive disorder? A qualitative review of safety
and efficacy. Psychiatry Res 2019;271:259‑64.
19. Lee C, Doo E, ChoiJM, Jang SH, Ryu HS, Lee JY, et al. The increased
level of depression and anxiety in irritable bowel syndrome
patients compared with healthy controls: Systematic review and
meta‑analysis. J Neurogastroenterol Motil 2017;23:349‑62.
20. Alhan C, Okan A. Irritable bowel syndrome, depression, and
anxiety. East J Med 2017;22:125‑9.
21. Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A,
Oliveira J, et al. Anxiety and depression comorbidities in irritable
bowel syndrome (IBS): A systematic review and meta‑analysis.
Eur Arch Psychiatry Clin Neurosci 2014;264:651‑60.
22. Cho HS, Park JM, Lim CH, Cho YK, Lee IS, Kim SW, et al. Anxiety,
depression and quality of life in patients with irritable bowel
syndrome. Gut Liver 2011;5:29‑36.
23. Burke PM, Kocoshis S, Neigut D, SauerJ, Chandra R, Orenstein D.
Maternal psychiatric disorders in pediatric inflammatory
bowel disease and cystic fibrosis. Child Psychiatry Hum Dev
1994;25:45‑52.
24. Rachman S. A cognitive theory of compulsive checking. Behav
Res Ther. 2002;40 (6):625‑639.
25. Kellner R. Psychosomatic syndromes, somatization and
somatoform disorders. Psychother Psychosom 1994;61:4‑24.
26. Barbara G, Cremon C, Stanghellini V. Inflammatory bowel disease
and irritable bowel syndrome: Similarities and differences. Curr
Opin Gastroenterol 2014;30:352‑8.
27. Graff LA, Walker JR, Bernstein CN. Depression and anxiety
in inflammatory bowel disease: A review of comorbidity and
management. Inflamm Bowel Dis 2009;15:1105‑18.
28. Prasko J, Jelenova D, Mihal V. Psychological aspects and
psychotherapy of inflammatory bowel diseases and irritable
bowel syndrome in children. Biomed Pap Med Fac Univ Palacky
Olomouc Czech Repub 2010;154:307‑14.
29. Gradus JL, Qin P, Lincoln AK, Miller M, Lawler E, Sørensen HT,
et al. Inflammatory bowel disease and completed suicide in Danish
adults. Inflamm Bowel Dis 2010;16:2158‑61.
30. Yoldascan E, Ozenli Y, Kutlu O, Topal K, Bozkurt AI. Prevalence
of obsessive‑compulsive disorder in Turkish university students
and assessment of associated factors. BMC Psychiatry 2009;9:40.
31. Salehi S, Mousavi AM, Sarichloo ME, Ghafelebashi H. Examined
demographic characteristics and signs of obsessive‑compulsive
disorder. Quarterly J Sabzevar Univ Med Sci 2014;21:343‑51.
32. Caraveo Anduaga JJ, Colmena] s BE. The epidemiology of
obsessive‑compulsive disorder in Mexico City. Salud Mental
2004;27:1‑6.
33. Subramaniam M, Abdin E, Vaingankar JA, Chong SA.
Obsessive‑compulsive disorder: Prevalence, correlates,
help‑seeking and quality of life in a multiracial Asian population.
Soc Psychiatry Psychiatr Epidemiol 2012;47:2035‑43.
34. Rajeziesfahani S. Comparing the Efficacy of Meta‑Cognitive
and Cognitive‑Behavioral Therapy on Patients Suffering
from Obsessive‑Compulsive Disorder. Ph.D Thesis Clinical
Psychology, Shahed University Faculty of Humanity Science;
2015.
35. Maroufi A, Zarei M, Gharibi F. Evaluation of imprinting pattern
in patients with obsessive‑compulsive disorder in Sanandaj. Sci
J Kurdistan Univ Med Sci 2014; 19 (1), 21‑29.
)